Indefinite Delivery Contract 75N95023D00009
Award Date
3/14/23
Last Date to Order
3/13/28
Federal Agency
National Institute on Drug Abuse
Awardee
Rutgers, The State University
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Employment Eligibility Verification
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The National Institute on Drug Abuse awarded Rutgers, The State University a single-award Indefinite Delivery Contract to establish and operate the NIDA Center for Genetic Studies. The contract has a potential value of $19.7 million over a five-year base period from September 2018 to September 2022. Rutgers has received multiple firm fixed price task orders against the contract to provide research services in support of the Center, including receiving, processing, storing, and distributing...
The National Institute on Drug Abuse (NIDA) has awarded an Indefinite Delivery Contract (IDC) to Infinity Biologix LLC, doing business as Sampled Division, to maintain and expand the NIDA Center for Genetic Studies (NCGS) over a 5-year period. The $15,000,000 contract aims to create a repository to receive, process, and store de-identified biospecimens and associated clinical and phenotypic data from NIDA-funded genetic addiction research, and to make these resources widely available to...
The National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services, has awarded an Indefinite Delivery Contract to Research Triangle Institute (RTI International), a non-profit research organization, to provide synthesis and distribution services for drugs of abuse and related compounds. The contract has a ceiling value of $14,004,330 and a period of performance from June 9, 2022 to June 8, 2027. This contract supports NIDA's mission of conducting...
The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a single-award Indefinite Delivery Contract to Research Triangle Institute (RTI International), a non-profit research organization, for the preparation and distribution of research drug products. The $19,975,000 contract has a period of performance from March 20, 2025 to March 19, 2029, with a final completion date of March 19, 2026 for the initial $1,497,865 delivery order. RTI International, an experienced...
The National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), has awarded an indefinite delivery/indefinite quantity (IDIQ) contract to The Emmes Company LLC, a for-profit limited liability company, to serve as the NIDA Data, Statistics, and Clinical Trial Support Center. Under this single-award IDIQ contract valued up to $31.2 million over a five-year period from September 2022 to September 2027, The...
This Indefinite Delivery Contract (IDC) was awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS), to New York University (NYU) School of Medicine. The $898,929.74 contract provides funding for an MTA (Mental Health Services Study) study under the DSIR (Drug Dependence Epidemiology Research) program. As an IDC, this contract provides a flexible mechanism for NIDA to issue task...
The Department of Homeland Security Science and Technology Directorate has awarded a single-award Basic Ordering Agreement (BOA) to Rutgers, The State University for a potential total value of $0.00. The BOA covers six thrust areas including the Coastal Hazards Center of Excellence and the Center of Excellence for Emerging and Zoonotic Infectious Diseases. Rutgers, a non-profit 1862 land grant educational institution, will provide a range of research and development services through this BOA....
The National Institutes of Health National Institute on Drug Abuse (NIDA) awarded an indefinite delivery contract to the nonprofit Research Triangle Institute (RTI) International for the Preparation and Distribution of Research Drug Products. The contract, valued at up to $19,975,000, has a period of performance from September 20, 2019 to September 19, 2024 and does not utilize any set-aside designations. Under this contract, RTI provides a variety of services to NIDA including the...
The National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), has awarded an Indefinite Delivery Contract (IDC) to Actuated Medical, Inc., doing business as Piezo Resonance Innovations Inc. The $35 million, single-award IDC runs through September 2028 and is for research and development services related to biocompatibility testing, animal studies, and sterilization testing in support of NIDA's Blueprint MedTech (BPMT) Initiative. This work involves...
The National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, awarded an Indefinite Delivery Contract (IDC) with a $49,500,000 ceiling value to The Emmes Company LLC, a for-profit limited liability company, to serve as the Clinical Coordinating Center for NIDA's Clinical Trials Network (CTN). The contract has a period of performance from August 15, 2024 to August 14, 2029. Under this IDC, NIDA has issued three task orders to date,...